DURATION OF FIRST REMISSION IN LEUKAEMIC RECIPIENTS OF LEUCOCYTE‐POOR BLOOD COMPONENTS
Paolo Rebulla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), G. Sirchia(Prime Minister's Office), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), G Isacchi(University of Bologna), F Malagnino(Sapienza University of Rome), Bruno Minetti(University of Bergamo), Maria Pappalettera, Tiziano Barbui(University of Bergamo)
Cited by 13
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
|Leukemia|2013|666
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
|Blood Cancer Journal|2018|632
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
|Biology of Blood and Marrow Transplantation|2009|595